Wu-Pu Lin

A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)

Cheng‐Pin Chen, Yi‐Chun Lin, Tsung‐Chia Chen et al. · PLoS ONE · 2020 · 81 citations · Full text

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials

Cathrine Axfors, Andreas M. Schmitt, Perrine Janiaud et al. · 2020 · 78 citations · Full text

Population Health Sciences, Pharmacotherapy, Covid-19 Epidemiology +21

The Antimicrobial Susceptibility of Klebsiella pneumoniae from Community Settings in Taiwan, a Trend Analysis

Wu-Pu Lin, Jann‐Tay Wang, Shan‐Chwen Chang et al. · Scientific Reports · 2016 · 60 citations · Full text

Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan

Wu-Pu Lin, Yu‐Shan Huang, Jann‐Tay Wang et al. · BMC Infectious Diseases · 2019 · 36 citations · Full text

Multimodal interventions for bundle implementation to decrease central line-associated bloodstream infections in adult intensive care units in a teaching hospital in Taiwan, 2009–2013

Wu-Pu Lin, Yu-Ching Chang, Un‐In Wu et al. · Journal of Microbiology Immunology and Infection · 2017 · 35 citations · Full text